It is the latest development in the effort to use a 19th century treatment to help 21st century patients. The contract with the DoD’s Joint Acquisition Task Force is to develop a new convalescent blood plasma process that makes more serum-derived products, and faster. President Donald Trump and U.S. health …
Read More »